A WORKSHOP ON AGRICULTURAL SPECIES AS BIOMEDICAL MODELS
Eric Wong
Rodents, especially mice, may rule supreme in the biomedical world as the model system of choice; however, there are situations in which mice may not be the ideal model system whereas an agricultural species may be. A workshop titled "Advantages of Agriculturally Important Domestic Animal Species as Biomedical Models" focused on the use of agricultural species as biomedical models. Over 100 participants from universities and federal agencies attended the workshop, held October 29-31, 2004, at Michigan State University.
A number of investigators presented their experiences with research projects that utilized agricultural species, such as chickens, pigs, cattle, and sheep, as biomedical models. Speakers were asked to discuss the following points in their presentations: the research focus and problem to be addressed; unique advantages of the domestic animal species as biomedical models; significance of findings for both human and animal health; and key elements and obstacles for successful funding.
The keynote address, "Are the domestic farm species redundant as models in biomedical research? Does mighty mouse rule supreme?", was presented by M. Roberts (University of Missouri). Other presentations discussed sheep as a model for nutritional biochemistry and prenatal programming of reproductive and metabolic dysfunction (G. Wu, Texas A&M; V. Padmanabhan, University of Michigan). Cattle were presented as a model for stem cell biology, immunobiology, and pathogen transmission (H. Lewin, University of Illinois; M. Jutila, Montana State University; G. Palmer, Washington State University; V. Kapur, University of Minnesota). The chicken, although not a mammal, also serves as a model for investigations in reproductive biology and diseases (J. Bahr, University of Illinois). Pigs are used for biomedical research on the cardiovascular system, cardiac arrhythmias, nutrition research, xenotransplantation, and adipose development and metabolism (R. Prather, University of Missouri; H. Laughlin, University of Missouri; R. Gilmour, Cornell University; J. Odle, North Carolina State University; D. Hausman, University of Georgia). The pig represented the most common model species, due to the similarity in anatomy and physiology between pig and human organs.
This workshop did not present a comprehensive representation of the roles that agricultural species play in biomedical research, but merely a sampling of successful research projects. Some common themes that emerged from the presentations included the perception that reviewers are not only unaware of alternative models, but may be biased against agricultural species. Strategies to counteract reviewer bias focused on a number of points, such as educating grant reviewers on the merits of agricultural species as a more appropriate model system. Furthermore, reviewers should be made aware that agricultural models have unique aspects that can be utilized to pioneer research to address gaps in knowledge of human health, not just confirm that of rodent models—i.e., the agricultural species may be a more suitable model than rodents, not just an alternative model.
Other obstacles discussed included the need for a critical mass of investigators, the lack of availability of reagents and tools, and the costs of doing research. Compared to mice, agricultural species lack comparable database resources, genomic information, and tools. For example, NIH funds $100M/year for pig research, yet the pig genome has yet to be sequenced. Chicken and bovine genomes have been sequenced, although neither is at the finished stage comparable to the human or mouse genome. For chickens, lack of an efficient method for generating transgenic chickens is a major obstacle to research. The high cost for purchasing, housing, and feeding agricultural species is an additional hindrance for all research with agricultural species. In addition, animal variability often necessitates use of greater numbers of animals to obtain statistically significant results, further driving up total cost. However, on the positive side, the large quantity of tissue available from agricultural species offers an advantage over rodents.
Grantsmanship for research on agricultural species was another topic of the workshop. Grant writing success generally follows the same formula, regardless of funding source. Good science is valued, first and foremost, and solid preliminary data are essential to success in grant funding. In some cases, investigators are able to use smaller USDA grants to obtain preliminary data that allowed them to compete for larger NIH grants. Senior investigators need to have a strong track record of publication in biomedical journals. Publishing in only the Journal of Animal Science or Poultry Science does not always reach the intended biomedical community.
Small groups of workshop participants addressed additional questions in two breakout sessions. Breakout Session I discussed the following questions:
• Are there any real or perceived barriers to using domestic species as models for biomedical research?
• In what ways will knowledge generated during the genomics, proteomics, and metabolomics era of research in digestive, reproductive, immune, and other systems benefit both animal agriculture and human medicine?
• Is justification of domestic animal use as models for biomedical research more difficult compared with rodent models?
Discussants in Breakout Session I determined that perceived barriers to using agricultural species as biomedical models were similar to those outlined by the presenters, such as availability of tools and reagents, knowledge and appreciation of agricultural models, adequacy of facilities, animal costs, institutional support, and ethical issues. Further, they suggested that the unique knowledge to be generated with agricultural species will help in understanding complex traits, population dynamics, epidemiology, and comparative functional genomics. There was the perception that use of domestic animals requires more justification because of the lack of appreciation of the models and understanding of the barriers. Therefore, more preliminary data may need to be submitted to convince reviewers of the merits of agricultural models.
In Breakout Session II, further questions were discussed:
• What is needed to enhance the use of domestic species as biomedical models?
• What are desired (and realistic) outcomes/expectations for the use of domestic animals as biomedical models?
• What are major constraints/barriers to achieving these goals?
• What strategies should be developed to enhance use of domestic species as biomedical models?
• How could greater cooperation be fostered between medical schools and animal science departments to use domestic species as biomedical models?
Some suggestions for enhancing use of domestic species as biomedical models included the following: increasing awareness of benefits of agricultural models, perhaps through symposia at biomedical meetings; increasing resources for databases and animal facilities; and developing grants for training integrative biologists. Another proposed strategy is the establishment of databases for central sharing of resources—the availability of mouse lines and cells and molecular biology reagents has greatly facilitated research with mice and would do the same for the agricultural species. The development of a joint NIH and USDA Request for Application (RFA) for alternative biomedical models would also enhance the use of agricultural species. Cooperation between medical schools and animal science departments could be strengthened by joint medical and agriculture school appointments and appropriation of institutional funds for interdisciplinary research. In addition, the physical (different campuses) and programmatic (different goals and research cultures) disconnect between agriculture and medical school programs needs to be addressed.
Information on the outcome of the workshop can be accessed at http://www.adsbm.msu.edu. The organizing/steering committee will develop a "white paper" to address issues relevant to the importance and future use of agricultural species as biomedical models. The projected outcomes of the recommendations from the workshop are the development of an interagency program on using agriculturally important species as biomedical models, a jointly sponsored USDA-NIH RFA that focuses on the use of domestic species as new or underutilized biomedical models, and the development of the genomics and proteomics tools and technologies for discovery science.
Clearly, the use of agricultural species as biomedical models has proven to be very successful in the past and will continue to flourish in the future. Enhanced use of agricultural species as research animals will benefit both animal agriculture and human medicine. The challenge will be to develop novel approaches to ensure that agricultural species are used as biomedical models in cases where mice are not the best models.
The white paper for the Workshop on Agricultural Species as Biomedical Models is now available at http://www.adsbm.msu.edu/whitepaper.html
Eric A. Wong
Department of Animal and Poultry Sciences
Virginia Tech
ewong@vt.edu
A GENE REPRESSION SYSTEM IN PLANTS VIA CHROMOSOME REMODELING BY HISTONE DEACETYLASES
Lining Tian, Brian Miki, Dan Brown & Keqiang Wu*
Introduction
Eukaryotic genes are regulated by a hierarchy of intricate controls that include modifications to chromatin structure. Within the primary chromatin fiber, DNA is packaged into nucleosomes by core histones. Posttranscriptional modification of nucleosomal histones, particularly through acetylation and deacetylation, is an important mechanism in the regulation of eukaryotic gene expression. Acetylation of the histones by acetyltransferases leads to a relaxed association, and thus, enhances accessibility of promoters to components of the transcription machinery and activates gene expression. Deacetylation of histones by histone deacetylases (HDACs) removes acetyl groups from the core histones. A reduction in the level of histone acetylation condenses chromatin, which obstructs transcription machinery access to gene regulatory elements, resulting in repression of transcription.
Different classes of HDACs have been identified in eukaryotes, including yeast, animals, and plants. Class I and II HDACs are homologous to yeast RPD3 and HDA1, respectively. In plants, functional studies indicate that RPD3 may provide housekeeping HDAC activity. Class III HDACs are related to the yeast silencing protein SIR2 and are dependent on nicotinamide adenine dinucleotide (NAD) for enzymatic activity. In addition to these three classes of HDACs, plants possess another type of HDAC, namely, the HD2 family. The HD2 family appears to be unique and unrelated to other classes of HDACs and shares some sequence similarity with the FKBP-type PPIases. Four members of HD2 are identified, HD2A, 2B, 2C, and 2D.
The role of histone deacetylases in transcription repression has been described in yeast and animals. In plants, involvement of histone deacetylases in the control of gene expression has not been studied. Here we report transcriptional repression by HDACs in plants and describe a system of using HDACs for repression of transgene expression. We explored proteins of HD2 and RPD3 classes of HDACs for repression and used yeast transcription factor, GAL4, or a plant transcription factor, to target an HDAC protein to the gene to be repressed. The study demonstrates that HDACs can effectively repress the expression of a transgene in plants.
Repression of expression via transient gene expression
Repression of gene expression by HDAC proteins was first tested via transient gene expression. A reporter vector was constructed in which a GUS reporter gene was driven by a strong constitutive promoter. Additionally, two copies of GAL4-binding sites (UASGAL4) were placed in front of the promoter in the reporter vector (Fig. 1). A second vector, effector, was also constructed. The effector contains an HD2 protein, HD2A, from Arabidopsis, and the protein was fused in frame with the DNA-binding domain of the yeast transcription factor GAL4 (GAL4BD). The fused protein was driven by another constitutive promoter (Fig. 1). It is expected that the reporter gene is repressed by GAL4-HD2A protein, which would target a promoter containing the GAL4-binding sites (UASGAL4). The reporter and effector plasmids were co-introduced into tobacco leaves by microprojectile bombardment. Analysis of transient GUS expression showed that HD2A proteins strongly repressed GUS gene expression when compared with expression of the reporter plasmid alone or in combination with a control effector plasmid that expressed the GAL4 protein only (Fig. 1). Different types of HDAC proteins, including HD2A, 2B, 2C, and RPD 3A were tested in the same manner and all these HDAC proteins exhibited repression. This suggests that HDACs can mediate transcriptional repression of a targeted reporter gene in vivo.